Acadia Connect

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing technology to fuel drug discovery and clinical development of treatments for central nervous system disorders. It has five drug programs in clinical and pre-clinical development directed at large unmet medical needs and major commercial markets. ACADIA s three Phase II-stage clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, ACP-103 as an adjunctive therapy for schizophrenia and ACP-104 for treatment of schizophrenia. The company also has clinical and pre-clinical development programs in the areas of neuropathic pain and glaucoma in collaboration with Allergan. ACADIA maintains headquarters and biology research facilities in San Diego and a chemistry research facility in Malmo, Sweden. It trades on NASDAQ under the symbol ACAD.

Genentech Inc in San Diego is dedicated to pioneering breakthrough science that impacts individuals on a personal level, one moment, one day, and one person at a time. The company's focus is on advancing scientific innovation to make a difference in the lives of individuals, emphasizing a commitment to progress and transformative discoveries. Generated from their website's infomation

Ciclofilin Pharmaceuticals Inc is a biopharmaceutical company based in San Diego, CA. The company specializes in developing innovative treatments for a range of medical conditions. With a focus on research and development, Ciclofilin Pharmaceuticals Inc aims to advance healthcare through the creation of novel pharmaceutical products. The company is committed to improving patient outcomes and addressing unmet medical needs. Generated from their business information